Literature DB >> 1849893

Mechanisms of mastoparan-stimulated surfactant secretion from isolated pulmonary alveolar type 2 cells.

M Joyce-Brady1, J B Rubins, M P Panchenko, J Bernardo, M P Steele, L Kolm, E R Simons, B F Dickey.   

Abstract

Mastoparan, a tetradecapeptide component of wasp venom, is a potent activator of secretion in a variety of cell types, and has been shown to activate purified G-proteins reconstituted into phospholipid vesicles with a preferential activation of Gi over Gs (Higashijima, T., Uzu, S., Nakajima, T., and Ross, E. R. (1988) J. Biol. Chem. 263, 6491-6494). To identify the biochemical activities of mastoparan in a cellular system, we characterized the effects of mastoparan on signal transduction pathways in rat pulmonary alveolar type 2 epithelial cells, which synthesize and secrete pulmonary surfactant. Mastoparan inhibited adenylylcyclase activity in a manner that was dose-dependent (IC50 = 30 microM), but sensitive to neither guanine nucleotide nor pertussis toxin (PT). Mastoparan induced a PT-sensitive increase in cellular inositol trisphosphate and a rapid rise in cytosolic calcium released from intracellular stores; the time to onset of the calcium rise, but neither the rate nor the amplitude of the rise, were PT-sensitive. Mastoparan also caused a dose- (EC50 = 16 microM) and time-dependent activation of arachidonic acid release that was completely insensitive to pretreatment with PT. Secretion of pulmonary surfactant was increased by mastoparan approximately 8-fold over constitutive levels at 1 h with an EC50 = 20 microM, and mastoparan-stimulated secretion was partially sensitive to PT at late time points and to inhibitors of arachidonic acid metabolism, but not to the protein kinase C inhibitor H7. These findings are consistent with the activation of Gi proteins in type 2 cells by mastoparan, although the lack of predicted triphosphoguanine nucleotide and PT sensitivity for some activities indicates that mastoparan does not act in a manner strictly analogous to liganded receptors or that some activities are not mediated by activation of Gi. While mastoparan is a potent secretagogue in several cell types, its secretory activity appears to have only a limited dependence on the activation of Gi proteins in type 2 cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849893

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Helminthes and insects: maladies or therapies.

Authors:  Nora L El-Tantawy
Journal:  Parasitol Res       Date:  2014-12-30       Impact factor: 2.289

2.  The neurotoxicological effects of mastoparan Polybia-MPII at the murine neuromuscular junction: an ultrastructural and immunocytochemical study.

Authors:  Thalita Rocha; Bibiana M de Souza; Mario S Palma; Maria Alice da Cruz-Höfling; John Buchanan Harris
Journal:  Histochem Cell Biol       Date:  2009-06-05       Impact factor: 4.304

3.  Mastoparan may activate GTP hydrolysis by Gi-proteins in HL-60 membranes indirectly through interaction with nucleoside diphosphate kinase.

Authors:  J F Klinker; A Hagelüken; L Grünbaum; I Heilmann; B Nürnberg; R Harhammer; S Offermanns; I Schwaner; J Ervens; K Wenzel-Seifert
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

4.  The effects of mastoparan on the carrot cell plasma membrane polyphosphoinositide phospholipase C.

Authors:  M H Cho; Z Tan; C Erneux; S B Shears; W F Boss
Journal:  Plant Physiol       Date:  1995-03       Impact factor: 8.340

5.  Effects of mastoparan upon the late stages of the ACTH secretory pathway of AtT-20 cells.

Authors:  B W McFerran; S B Guild
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

6.  Three alternative promoters of the rat gamma-glutamyl transferase gene are active in developing lung and are differentially regulated by oxygen after birth.

Authors:  M Joyce-Brady; S M Oakes; D Wuthrich; Y Laperche
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.